Thyrocare Technologies (THYROCARE) — Buyback / Redemption

📢 Key Event
Promoter releases pledge on 7,94,69,696 shares after NCD repayment.

🔄 What Changed
Release of pledge removes encumbrance on 7,94,69,696 shares; promoter now holds 8,12,00,000 shares (51.02%) free of any pledge.

💡 Investor Takeaway
The removal of pledge eliminates a key overhang on shareholding transparency and reduces perceived risk for investors.

Thyrocare announced that promoter Docon Technologies released a pledge on 7,94,69,696 equity shares following full repayment of INR 10,500 million Non-Convertible Debentures by API Holdings on August 14, 2026. The release removes all encumbrances on promoter-held shares, leaving Docon with 8,12,00,000 shares (51.02% of total) free of any pledge or lien, fully complying with SEBI SAST Regulations disclosures.

📄 View Original Announcement (PDF)

📊 Stock Analysis — THYROCARE ✨ Ask AI About This

About Thyrocare Technologies Limited (THYROCARE)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹9,402.69 Cr P/E: 34.6 ROE: 34.3% ROCE: 45.6% Div Yield: 1.18%

View full THYROCARE stock details →

📡 Get AI alerts when THYROCARE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track THYROCARE — Free

💡 Ask AI about this filing

"What is the current shareholding pattern of Docon post-release?" "How does the NCD repayment affect API Holdings' financial obligations?" "What impact does full share release have on Thyrocare's market valuation?"

Ask AI Free →

📊 More THYROCARE filings

See all THYROCARE filings →

🔥 Also filed on 17 August 2026

PREMIERENE Premier Energies Limited Announcement ABCAPITAL Aditya Birla Capital Limited Corporate Action VIVIMEDLAB Vivimed Labs Limited Announcement GSPCROP GSP Crop Science Limited Financial Results SEDEMAC SEDEMAC Mechatronics Limited Annual Report AFFLE Affle 3i Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when THYROCARE files new disclosures

Track THYROCARE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track THYROCARE — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd